Co-targeting serine/threonine kinases to overcome drug resistance in cancer
Serine/threonine kinases are activated in cancer & phosphorylate overlapping substrates. Although promising targets for cancer therapy, drug resistance is a challenge. Co-targeting strategies may be more efficacious & provide more durable responses.
Translations available below :
Report a problem
Is this content inappropriate?